Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Cisplatin in Advanced Head and Neck Cancer
NCT00003182Phase 2Unknown
- Sponsor
- Hope Cancer Institute, Inc.
- Start
- Mar 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in head and neck squamous cell carcinoma (HNSCC), sponsored by Hope Cancer Institute, Inc.. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00003182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003182.